1.
New insights on the role of apoptosis and autophagy in HIV pathogenesis
by Gougeon, M.-L
Apoptosis (London), 2009-02-06, Vol.14 (4), p.501-508
2.
Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy : correlation between dyslipidaemia and steroid hormone alterations
by CHRISTEFF, N
AIDS (London), 1999, Vol.13 (16), p.2251-2260
3.
Programmed cell death in AIDS-related HIV and SIV infections
by GOUGEON, M.-L
AIDS research and human retroviruses, 1993, Vol.9 (6), p.553-563
4.
Increased priming for interleukin-12 and tumour necrosis factor alpha in CD64 monocytes in HIV infection: modulation by cytokines and therapy
by Bocchino, M
AIDS (London), 2001-07-06, Vol.15 (10), p.1213-1223
5.
The conserved carboxy terminal region of HIV-1 gp120 is recognized by seronegative HIV-exposed people
by BROWN, L
AIDS (London), 1999, Vol.13 (18), p.2515-2521
6.
New concepts in AIDS pathogenesis
by GOUGEON, M.-L
AIDS research and human retroviruses, 1993, Vol.9 (3), p.287-289
7.
Innate T cell immunity to HIV-infection: Immunotherapy with phosphocarbohydrates, a novel strategy of immune intervention?
by Gougeon, M.L
Vaccine, 2002, Vol.20 (15), p.1938-1941
8.
Immunological and virological effects of long term IL-2 therapy in HIV-1-infected patients
by GOUGEON, Marie-Lise
AIDS (London), 2001, Vol.15 (13), p.1729-1731
9.
Lack of control of T cell apoptosis under HAART. Influence of therapy regimen in vivo and in vitro
by DE OLIVEIRA PINTO, Luzia Maria
AIDS (London), 2002, Vol.16 (3), p.329-339
10.
A placebo-controlled clinical phase I trial with combined anti-HIV-1 and anti-interferon-alpha immunization
by Coulaud, I P
AIDS (London), 1997-06, Vol.11 (7), p.937-938
11.
Is a dominant superantigen involved in AIDS pathogenesis?
by Gougeon, Marie-Lise
The Lancet (British edition), 1993, Vol.342 (8862), p.50-51
12.
Alternative cytotoxic effector mechanisms in infections with immunodeficiency viruses: gamma delta T lymphocytes and natural killer cells
by Malkovsky, M
AIDS (London), 2000-01-01, Vol.14, p.S175-S186
13.
Hyper-IgM immunodeficiency syndrome: influence of lymphokines on in vitro maturation of peripheral B cells
by Gougeon, M L
Journal of clinical immunology, 1992-03, Vol.12 (2), p.92-100
14.
Effect of intermittent interleukin-2 therapy on CD4 super(+) T-cell counts following antiretroviral cessation in patients with HIV
by Levy, Y
AIDS (London), 2012-01-01, Vol.26 (6), p.711-720
15.
Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial
by Levy, Yves
AIDS (London), 2003-02, Vol.17 (3), p.343-351
16.
Alternative cytotoxic effector mechanisms in infections with immunodeficiency viruses: gammadelta T lymphocytes and natural killer cells
by Malkovsky, M
AIDS (London), 2000, Vol.14 Suppl 3, p.S175-S186
17.
Vaccine therapy in early HIV-1 infection using a recombinant canarypox virus expressing gp160 sub(MN) (ALVAC-HIV): A double-blind controlled randomized study of safety and immunoge...
by Tubiana, R
AIDS (London), 1997-05-01, Vol.11 (6), p.819-820
18.
Vaccine therapy in early HIV-1 infection using a recombinant canarypox virus expressing gp160MN (ALVAC-HIV): a double-blind controlled randomized study of safety and immunogenicity
by Tubiana, R
AIDS (London), 1997-05, Vol.11 (6), p.819-820
19.
Hyper-IgM immunodeficiency syndrome : influence of lymphokines on in vitro maturation of peripheral B cell
by GOUGEON, M.-L
Journal of clinical immunology, 1992, Vol.12 (2), p.92-100
